QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
QQQ   305.97 (+0.35%)
AAPL   157.40 (+1.55%)
MSFT   272.23 (-2.58%)
META   197.81 (+1.12%)
GOOGL   101.22 (-0.39%)
AMZN   97.71 (-1.25%)
TSLA   183.25 (+1.73%)
NVDA   259.00 (+0.68%)
NIO   8.75 (+5.93%)
BABA   81.00 (-0.82%)
AMD   96.81 (-1.05%)
T   18.49 (+1.99%)
F   11.18 (-1.06%)
MU   57.64 (+1.73%)
CGC   1.86 (-7.00%)
GE   89.92 (-0.41%)
DIS   94.22 (+1.09%)
AMC   4.27 (+2.15%)
PFE   40.81 (+1.77%)
PYPL   73.21 (+0.30%)
NFLX   305.13 (+0.54%)
CVE:SCYB

Scythian Biosciences - SCYB Stock Forecast, Price & News

C$3.49
-0.22 (-5.93%)
(As of 07/25/2018)
Add
Compare
Today's Range
C$3.46
C$3.77
50-Day Range
C$3.49
C$3.49
52-Week Range
C$1.01
C$8.61
Volume
703,164 shs
Average Volume
231,491 shs
Market Capitalization
C$102.38 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Scythian Biosciences

Scythian Biosciences Corp. engages in the research and development of cannabinoid-based combination drug therapies for the treatment of concussions and traumatic brain injury. It also develops drug candidates for the treatment of gastro-intestinal inflammatory issues. The company is headquartered in Toronto, Canada.

Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

SCYB Stock News Headlines

Ventrus Biosciences (VTUS) Stock Surges Today
Buy THIS stock before Taiwan is attacked
... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.
Canadian Jobs to be Presented Next Friday
Scythian Biosciences Appoints Brady Cobb as CEO
See More Headlines
Receive SCYB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scythian Biosciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$102.38 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Rob Reid
    CEO & Director
  • Mr. Jonathan James Held (Age 32)
    Chief Financial Officer
  • Mr. Maghsoud Dariani (Age 65)
    Chief Scientific Officer
  • Prof. Michael Barnes
    Chief Medical Officer













SCYB Stock - Frequently Asked Questions

How have SCYB shares performed in 2023?

Scythian Biosciences' stock was trading at C$3.49 at the beginning of the year. Since then, SCYB shares have increased by 0.0% and is now trading at C$3.49.
View the best growth stocks for 2023 here
.

What other stocks do shareholders of Scythian Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scythian Biosciences investors own include Cross Timbers Royalty Trust (CRT), Archer-Daniels-Midland (ADM), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Organigram (OGI), Roku (ROKU), Scythian Biosciences (SCCYF) and Abbott Laboratories (ABT).

What is Scythian Biosciences' stock symbol?

Scythian Biosciences trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SCYB."

How do I buy shares of Scythian Biosciences?

Shares of SCYB stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Scythian Biosciences' stock price today?

One share of SCYB stock can currently be purchased for approximately C$3.49.

How much money does Scythian Biosciences make?

Scythian Biosciences (CVE:SCYB) has a market capitalization of C$102.38 million.

How can I contact Scythian Biosciences?

Scythian Biosciences' mailing address is 366 Bay St Suite 200, TORONTO, ON M5H 4B2, Canada. The official website for the company is scythianbio.com. The company can be reached via phone at +1-416-3669192.

This page (CVE:SCYB) was last updated on 3/20/2023 by MarketBeat.com Staff